Skip to main content

1-Methyl-4-(tricyclo[9.4.0.0<sup>3,8</sup>]pentadeca-1,3,5,7,9,11,13-heptaenylidene)piperidine

ADVERTISEMENT
Identification
Molecular formula
C25H25N
CAS number
.
IUPAC name
1-methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine
State
State

At room temperature, the compound is typically found in a solid state. It is crystalline, and its polycyclic structure contributes to its stability in this form.

Melting point (Celsius)
132.00
Melting point (Kelvin)
405.15
Boiling point (Celsius)
320.00
Boiling point (Kelvin)
593.15
General information
Molecular weight
339.47g/mol
Molar mass
339.4740g/mol
Density
1.0000g/cm3
Appearence

The compound appears as a solid crystalline material with a complex hydrocarbon structure featuring multiple rings and a piperidine moiety. It is a complex organic molecule with an intricate structure that may display different characteristics depending on its crystalline form.

Comment on solubility

Solubility of 1-methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine (C25H25N)

The solubility of 1-methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine can be quite intriguing due to its unique structural characteristics. Here are some key points to consider regarding its solubility:

  • Solvent Dependency: The solubility might significantly depend on the choice of solvent. Non-polar solvents may facilitate better solubility due to the hydrophobic characteristics of the compound.
  • Temperature Effects: As with many organic compounds, increasing the temperature might enhance solubility, allowing for greater molecular interactions with the solvent molecules.
  • Functional Groups: The presence of nitrogen in the piperidine ring could introduce different polarity aspects, which might affect how well the compound dissolves in various solvents.
  • Complex Formation: It might engage in complex formation with certain solvents, enhancing solubility in specific cases.

Understanding the solubility of C25H25N is essential for various applications including its potential use in drug formulation and material science. As always, empirical testing in different mediums is vital to gain precise insights.

Interesting facts

Interesting Facts about 1-Methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine

This intriguing compound belongs to the family of piperidines, known for their versatility and presence in numerous natural products and pharmaceuticals. Here are some captivating aspects of this compound:

  • Complex Structure: The compound features a unique tricyclic framework, which enhances its structural complexity compared to more straightforward piperidine derivatives. This intricate architecture can influence its chemical behavior and reactivity.
  • Modified Functionality: The presence of the 1-methyl group and the tricyclo fragment introduces specific steric and electronic properties, potentially affecting biological activity. This modification is key in drug design.
  • Applications in Research: Compounds like this one have been examined for their potential in medicinal chemistry. Researchers are particularly interested in their interactions with biological targets, making them candidates for further exploration in therapeutic applications.
  • Chemical Versatility: The functional groups and cyclic structure suggest that this compound may undergo a variety of reactions, opening up avenues for synthesis and further derivatization in laboratory settings.
  • Nature-Inspired Synthesis: This compound exemplifies how synthesis can replicate complex structures found in nature, which is a fundamental aspect of organic chemistry and can lead to the development of novel materials.

The bold, imaginative structure of 1-Methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine serves as a reminder of the creativity inherent in the field of chemistry. As noted by many chemists, "The beauty of chemistry lies in the endless possibilities of combining elements into innovative and unpredictable forms."

Exploring this compound may reveal fascinating insights into how structural modifications can influence properties, potentially paving the way for advancements in various scientific disciplines.

Synonyms
CYPROHEPTADINE
129-03-3
Periactin
Eiproheptadine
Periactinol
Dronactin
Ciproheptadina
4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-methylpiperidine
Cyproheptadinum
Ciprovit
Periactine
Peritol
MK 141
4-(5H-Dibenzo(a,d)cyclohepten-5-ylidene)-1-methylpiperidine
1-Methyl-4-(5H-dibenzo(a,d)cycloheptenylidene)piperidine
Cyproheptadinum [INN-Latin]
5-(1-Methylpiperidylidene-4)-5H-dibenzo(a,d)cyclopheptene
1-Methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine
4-(5-Dibenzo(a,d)cyclohepten-5-ylidine)-1-methylpiperidine
Ciproheptadina [INN-Spanish]
cycloheptadine
cyproheptidine
CCRIS 5232
HSDB 3048
EINECS 204-928-9
UNII-2YHB6175DO
BRN 1685976
2YHB6175DO
CHEBI:4046
Cyproheptadine (INN)
DTXSID8022872
Piperidine, 4-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-methyl-
4-(5H-Dibenzo(a,d)cyclohepten-5-ylidene)-1-methylpiperidene
4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-methylpiperidine
CHEMBL516
Piperidine, 4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-methyl-
1-Methyl-4-(5H-dibenzo[a,d]cycloheptenylidene)piperidine
DTXCID702872
Cypoheptadine
Cyproheptadiene
5-20-08-00500 (Beilstein Handbook Reference)
1-methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine
NCGC00015252-08
41354-29-4
CYPROHEPTADINE [INN]
Cyproheptadinum (INN-Latin)
Ciproheptadina (INN-Spanish)
Cyproheptadine [INN:BAN]
4-Dibenzo[a,d]cyclohepten-5-ylidene-1-methyl-piperidine
Ciprovit (TN)
CAS-129-03-3
4-Dibenzo(a,d)cyclohepten-5-ylidene-1-methyl-piperidine
ciproeptadina
Cyproheptadin
Reactin
4-(5H-dibenzo(a,d)(7)annulen-5-ylidene)-1-methylpiperidine
Peritol (Salt/Mix)
Tocris-0996
Prestwick0_000103
Prestwick1_000103
Prestwick2_000103
Prestwick3_000103
Cyproheptadine (Standard)
Lopac-C-6022
Biomol-NT_000131
CYPROHEPTADINE [MI]
SCHEMBL4021
4-(5H-DIBENZO
Lopac0_000246
Oprea1_498140
BSPBio_000086
CYPROHEPTADINE [HSDB]
GTPL277
BIDD:GT0324
CYPROHEPTADINE [VANDF]
SPBio_002025
BPBio1_000096
BPBio1_000155
CYPROHEPTADINE [WHO-DD]
HY-B1622R
R06AX02
1-METHYL-4-(5-DIBENZO
1-METHYL-4-(5H-DIBENZO
HMS2090P20
HY-B1622
Tox21_110112
BBL010977
BDBM50017721
DL-136
PDSP1_001229
PDSP2_001213
STK802098
AKOS004119847
Tox21_110112_1
CCG-204341
DB00434
SDCCGSBI-0050234.P003
NCGC00015252-01
NCGC00015252-02
NCGC00015252-03
NCGC00015252-04
NCGC00015252-05
NCGC00015252-06
NCGC00015252-07
NCGC00015252-09
NCGC00015252-10
NCGC00015252-12
NCGC00015252-13
NCGC00015252-26
NCGC00024293-02
NCGC00024293-04
NCGC00024293-05
CAS-969-33-5
VS-02784
SBI-0050234.P002
DB-041917
DB-241419
CS-0013555
NS00004763
C06935
D07765
5-(1-METHYLPIPERIDYLIDENE-4)-5H-DIBENZO
EN300-18552723
L001016
Q417884
BRD-K28143534-001-01-4
BRD-K28143534-001-02-2
BRD-K28143534-001-03-0
BRD-K28143534-003-03-6
BRD-K28143534-003-14-3
BRD-K28143534-003-24-2
BRD-K28143534-003-25-9
BRD-K28143534-003-26-7
4-(dibenzo[[?],[?]][7]annulen-11-ylidene)-1-methyl-piperidine
4-(Dibenzo[1,2-A:2',1'-D][7]annulen-11-Ylidene)-1-Methyl-Piperidine
1-methyl-4-{tricyclo[9.4.0.0(3),?]pentadeca-1(11),3,5,7,9,12,14-heptaen-2-ylidene}piperidine
1-methyl-4-{tricyclo[9.4.0.0,3,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-ylidene}piperidine
1-methyl-4-{tricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-ylidene}piperidine
1-methyl-4-{tricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,9,11,13-heptaen-2-ylidene}piperidine
204-928-9
4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-methylpiperidine4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-methylpiperidine
Cycloheptadine; Piperidine, 4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-methyl-; 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-methylpiperidine; 1-Methyl-4-(5H-dibenzo[a,d]cycloheptenylidene)piperidine; 1-Methyl-4-(dibenzo[a,e]cycloheptatrien-5-ylidene)piperidine; Cyclohepta